Published on 20 May 2024 on Zacks · via Yahoo Finance
Medpace (MEDP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this provider of outsourced clinical development services have returned -2.5% over the past month versus the Zacks S&P 500 composite's -0.3% change. The Zacks Medical Services industry, to which Medpace belongs, has lost 0.2% over this period. Now the key question is: Where could the stock be headed in the near term?